Cost of MS drugs may skyrocket following Medicare rule change
Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis.
Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis.